JBMR Plus · 2018 · 23 citations · 61 references
MedicineChild HealthPediatricsPediatric DisabilityPediatric EndocrinologyPediatric NeurologyPediatric Musculoskeletal DisordersPediatric Physical Examination6-Minute Walk TestChange ScaleClinical Validation StudiesCorrelationMinimally Important DifferencePediatric Motor AssessmentTest-retest ReliabilityTest-retest Reproducibility
ABSTRACT This investigation evaluated the reliability and validity of the 6‐Minute Walk Test (6MWT) in patients with pediatric hypophosphatasia (HPP). Children (aged 6 to 12 years; n = 11), adolescents (13 to 17 years; n = 4), and adults (18 to 65 years; n = 9) completed the 6MWT at screening and baseline in two clinical studies of asfotase alfa. Test‐retest reliability of the 6MWT, evaluated with Pearson's correlation coefficients ( r ) for screening versus baseline, was high for children ( r = 0.95; p < 0.0001), adolescents ( r = 0.81; p = 0.125), and adults ( r = 0.94; p = 0.0001). The most conservative minimal clinically important differences, estimated using distribution‐based methods, were 31 m (children and adults) and 43 m (adolescents). In children, the 6MWT correlated significantly with scores on measures of skeletal disease, which included the Radiographic Global Impression of Change scale ( r = 0.50; p < 0.0001) and the Rickets Severity Scale ( r = −0.78; p < 0.0001), such that distance walked increased as the severity of skeletal disease decreased. Significant ( p < 0.0001) correlations with the 6MWT distance walked were also observed for children with scores on parent‐reported measures of disability ( r = −0.67), ability to function in activities of daily living ( r = 0.71 to 0.77), and parent‐reported measures of pain ( r = −0.39). In adolescents and adults, 6MWT distance walked correlated significantly ( p < 0.05) with measures of lower extremity function ( r = 0.83 and 0.60, respectively), total pain severity ( r = −0.41 and −0.36, respectively), and total pain interference ( r = −0.41 and −0.49, respectively). Collectively, these data indicate that the 6MWT is a reliable, valid measure of physical functioning in patients with pediatric HPP. © 2018 The Authors. JBMR Plus Published by Wiley Periodicals, Inc. on behalf of the American Society for Bone and Mineral Research.
61
Pain assessment: global use of the Brief Pain Inventory.
Cleeland Cs, Ryan Km · PubMed · 1994 · 5.3K citations
Two-, six-, and 12-minute walking tests in respiratory disease.
R. J. A. Butland, J. A. Pang, E R Gross et al. · BMJ · 1982 · 1.7K citations · Full text
Jill Binkley, Paul W. Stratford, Stacy Lott et al. · PubMed · 1999 · 1.4K citations
Measurement of health status in children with juvenile rheumatoid arthritis
Gurkirpal Singh, Balu H. Athreya, James F. Fries et al. · Arthritis & Rheumatism · 1994 · 856 citations
Medicine, Child Health, Pediatrics +13